VICRYL PLUS POLYGLACTIN 910 SUTURE UNKNOWN PROD
Report
- Report Number
- 2210968-2017-71466
- Event Type
- Injury
- Date Received
- November 28, 2017
- Report Date
- December 7, 2017
- Manufacturer
- ETHICON INC.
- Product Code
- GAM
- PMA / PMN Number
- K032420
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SW
- Reporter Occupation
- OTHER
Narratives
(B)(4). TO DATE THE DEVICE HAS NOT BEEN RETURNED. IF THE DEVICE OR FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. ATTEMPTS ARE BEING MADE TO OBTAIN THE FOLLOWING INFORMATION. TO DATE NO RESPONSE HAS BEEN PROVIDED. IF FURTHER DETAILS ARE RECEIVED AT A LATER DATE A SUPPLEMENTAL MEDWATCH WILL BE SENT. DOES THE SURGEON BELIEVE THAT ETHICON SUTURES CAUSED AND/OR CONTRIBUTED TO THE ADVERSE EVENTS DESCRIBED IN THE ARTICLE? IS THE PRODUCT CODE AND LOT NUMBER AVAILABLE FOR ANY OF THE ETHICON DEVICES USED? CITATION: EUR J CLIN MICROBIOL INFECT DIS 2015;34:2331-2338. DOI 10.1007/S10096-015-2485-8 .
PRODUCT COMPLAINT # ==> PC-000057106 ADDITIONAL INFORMATION WAS REQUESTED AND THE FOLLOWING WAS OBTAINED: WERE THE CASES DISCUSSED IN THIS ARTICLE PREVIOUSLY REPORTED TO ETHICON? IF YES, PLEASE PROVIDE A COMPLAINT REFERENCE NUMBER. NO DOES THE SURGEON BELIEVE THAT ETHICON PRODUCT MONOCRYL PLUS AND/ OR MONOCRYL, VICRYL OR VICRYL PLUS SUTURES CAUSED AND/OR CONTRIBUTED TO THE ADVERSE EVENTS DESCRIBED IN THE ARTICLE? NO IS THE PRODUCT CODE AND LOT NUMBER AVAILABLE FOR ANY OF THE ETHICON DEVICES USED? NO
IT WAS REPORTED IN JOURNAL ARTICLE ¿TRICLOSAN-COATED SUTURES AND STERNAL WOUND INFECTIONS: A PROSPECTIVE RANDOMIZED CLINICAL TRIAL¿ THAT THE PURPOSE OF THIS PROSPECTIVE RANDOMIZED DOUBLE-BLIND SINGLE-CENTER STUDY WAS TO COMPARE THE RATE OF INFECTIONS IN STERNOTOMY WOUNDS CLOSED WITH TRICLOSAN-COATED OR CONVENTIONAL SUTURES. PATIENTS WERE RECRUITED BETWEEN MARCH 1, 2009 AND FEBRUARY 15, 2012. 357 PATIENTS WERE RANDOMIZED TO CLOSURE OF THE SURGICAL WOUNDS WITH EITHER TRICLOSAN-COATED SUTURES OR IDENTICAL SUTURES WITHOUT TRICLOSAN. IN THE TRICLOSAN GROUP (N=179; 41 WOMEN, 138 MEN; MEAN AGE 67.6+/-8.1 YEARS; MEAN BMI 27.7+/-4.1 KG/M2), THE FASCIA AND THE SUBCUTANEOUS TISSUE WERE CLOSED WITH TRICLOSAN-COATED SUTURE. STERNAL WOUND INFECTION OCCURRED IN 12.8% (N=23: DEEP INFECTION, N=3; SUPERFICIAL INFECTION, N=20) IN THE TRICLOSAN GROUP. THERE WERE 16 POSITIVE CULTURES IN THE TRICLOSAN GROUP. THE MOST COMMON PATHOGENS IN BOTH GROUPS WERE (B)(6) AND COAGULASE-NEGATIVE STAPHYLOCOCCI. ANTIBIOTIC-TREATED STERNAL WOUND INFECTION WAS 13.4% (N=24) FOR BOTH GROUPS. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 843261 | VICRYL PLUS POLYGLACTIN 910 SUTURE UNKNOWN PROD | SUTURE, ABSORBABLE, SYNTHETIC | GAM | ETHICON INC. | UNK |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Required Intervention |